DE

The Future Map · technological enabler · active

Biomaterials & Biofabrication

Maturity

2 / 5

Basis, source, vintage

Real commercial production at a marginal share of plastics, with capacity running well ahead of output.

Source: European Bioplastics / nova-Institute, Bioplastics Market Development Update 2024 (Dec 2024): 2.47 Mt capacity, 1.44 Mt actual production (58% utilisation), packaging 45%. The 2025 update puts bioplastics at ~0.5% of 431 Mt of plastics produced annually (2024)

What it is

Materials grown or derived from biological processes — bio-based plastics, mycelium composites, bioprinted tissue and biomimetic structures.

What it does

It offers substitution rather than efficiency: replacing a material whose production is the problem, instead of using less of it. That is a different and more durable route to reducing throughput.

Common misconception

That bio-based means benign. Land use, water use and end-of-life behaviour vary enormously, and some bio-based plastics are neither compostable in practice nor recyclable in existing streams.

Steepens

A megatrend runs at the pace of its shallowest enabler. Marginal links are shown but never set the pace.

What would change its gradient

Shares megatrends with

In the book

Why the Future Arrives Unevenly — Ch. 8 — The Rebuild of the Physical Base · Ch. 9 — The Closing of the Planetary Envelope

Sources


See it in the map →

Cite this entry

Talin, B. (2026). Biomaterials & Biofabrication. The Future Map, dataset v0.4.0 (2026-09-07). https://futuremap.talin.digital/e/biomaterials-and-biofabrication/

Machine view: This entry as Markdown · The whole map as JSON

Updated 2026-09-02.